The benefit of using bladder sub-volume equivalent uniform dose constraints in prostate intensity-modulated radiotherapy planning

被引:15
|
作者
Zhu, Jian [1 ,2 ,3 ]
Simon, Antoine [3 ,4 ,5 ]
Haigron, Pascal [3 ,4 ,5 ]
Lafond, Caroline [4 ,5 ,6 ]
Acosta, Oscar [4 ,5 ]
Shu, Huazhong [1 ,3 ]
Castelli, Joel [4 ,5 ,6 ]
Li, Baosheng [1 ,2 ,3 ]
De Crevoisier, Renaud [3 ,4 ,5 ,6 ]
机构
[1] Southeast Univ, Lab Image Sci & Technol, Sipailou 2, Nanjing 210096, Jiangsu, Peoples R China
[2] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
[3] Ctr Rech Informat Biomed Sino Francais, Nanjing, Jiangsu, Peoples R China
[4] INSERM, U1099, Rennes, France
[5] Univ Rennes 1, Lab Signal & Image Proc LTSI, Rennes, France
[6] Ctr Eugene Marquis, Dept Radiotherapy, Rennes, France
来源
ONCOTARGETS AND THERAPY | 2016年 / 9卷
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
prostate; IMRT; equivalent uniform dose; 3-DIMENSIONAL CONFORMAL RADIOTHERAPY; RADIATION-THERAPY; PREDICTIVE MODELS; URINARY TOXICITY; 2.5; GY; CANCER; OPTIMIZATION; IMRT; ESCALATION; ALPHA/BETA;
D O I
10.2147/OTT.S116508
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: To assess the benefits of bladder wall sub-volume equivalent uniform dose (EUD) constraints in prostate cancer intensity-modulated radiotherapy (IMRT) planning. Methods: Two IMRT plans, with and without EUD constraints on the bladder wall, were generated using beams that deliver 80 Gy to the prostate and 46 Gy to the seminal vesicles and were compared in 53 prostate cancer patients. The bladder wall was defined as the volume between the external manually delineated wall and a contraction of 7 mm apart from it. The bladder wall was then separated into two parts: the internal-bladder wall (bla-in) represented by the portion of the bladder wall that intersected with the planning target volume (PTV) plus 5 mm extension; the external-bladder wall (bla-ex) represented by the remaining part of the bladder wall. In the IMRT plan with EUD constraints, the values of "a" parameter for the EUD models were 10.0 for bla-in and 2.3 for bla-ex. The plans with and without EUD constraints were compared in terms of dose-volume histograms, 5-year bladder and rectum normal tissue complication probability values, as well as tumor control probability (TCP) values. Results: The use of bladder sub-volume EUD constraints decreased both the doses to the bladder wall (V-70: 22.76% vs 19.65%, D-mean: 39.82 Gy vs 35.45 Gy) and the 5-year bladder complication probabilities (>= LENT/SOMA Grade 2: 20.35% vs 17.96%; bladder bleeding: 10.63% vs 8.64%). The doses to the rectum wall and the rectum complication probabilities were also slightly decreased by the EUD constraints compared to physical constraints only. The minimal dose and the V-76Gy of PTVprostate were, however, slightly decreased by EUD optimization, nevertheless without significant difference in TCP values between the two plans, and the PTV parameters finally respected the Groupe d'Etude des Tumeurs Uro-Genitales recommendations. Conclusion: Separating the bladder wall into two parts with appropriate EUD optimization may reduce bladder toxicity in prostate IMRT. Combining biological constraints with physical constraints in the organs at risk at the inverse planning step of IMRT may improve the dose distribution.
引用
收藏
页码:7537 / 7544
页数:8
相关论文
共 50 条
  • [1] Dosimetric benefit of DMLC tracking for conventional and sub-volume boosted prostate intensity-modulated arc radiotherapy
    Pommer, Tobias
    Falk, Marianne
    Poulsen, Per R.
    Keall, Paul J.
    O'Brien, Ricky T.
    Petersen, Peter Meidahl
    af Rosenschold, Per Munck
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2013, 58 (07): : 2349 - 2361
  • [2] Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose
    Wu, QW
    Mohan, R
    Niemierko, A
    Schmidt-Ullrich, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (01): : 224 - 235
  • [3] The generalized equivalent uniform dose function as a basis for intensity-modulated treatment planning
    Choi, B
    Deasy, J
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2002, 47 (20): : 3579 - 3589
  • [4] Benefit of Equivalent Uniform Dose in Prostate IMRT Planning to Reduce Bladder Toxicity
    Zhu, J.
    Simon, A.
    Haigron, P.
    Lafond, C.
    Acosta, O.
    Shu, H.
    Castelli, J.
    Li, B.
    De Crevoisier, R.
    [J]. MEDICAL PHYSICS, 2015, 42 (06) : 3236 - 3236
  • [5] Dosimetric advantages of generalised equivalent uniform dose-based optimisation on dose-volume objectives in intensity-modulated radiotherapy planning for bilateral breast cancer
    Lee, T-F
    Ting, H-M
    Chao, P-J
    Wang, H-Y
    Shieh, C-S
    Horng, M-F
    Wu, J-M
    Yeh, S-A
    Cho, M-Y
    Huang, E-Y
    Huang, Y-J
    Chen, H-C
    Fang, F-M
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2012, 85 (1019): : 1499 - 1506
  • [6] Dose painting in intensity-modulated radiotherapy for prostate cancer
    Oehler, W
    Baum, RP
    Buth, KJ
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 53 - 53
  • [7] Outcomes of Intensity-modulated Radiotherapy for Prostate Cancer using an Empty Bladder Protocol
    Tuan, J. K. L.
    Ha, T. C.
    Ong, W. S.
    Siow, T. R.
    Tham, I. W. K.
    Ng, W. L.
    Wang, M. L. C.
    Chua, E. T.
    Tan, T. W. K.
    [J]. CLINICAL ONCOLOGY, 2012, 24 (09) : E137 - E139
  • [8] Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer
    Vargas, Carlos
    Fryer, Amber
    Mahajan, Chaitali
    Indelicato, Daniel
    Horne, David
    Chellini, Angela
    Mckenzie, Craig
    Lawlor, Paula
    Henderson, Randal
    Li, Zuofeng
    Lin, Liyong
    Olivier, Kenneth
    Keole, Sameer
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (03): : 744 - 751
  • [9] Concave Approximations of Target Volume Dose Metrics for Intensity-Modulated Radiotherapy Treatment Planning
    Xie, Y.
    Chen, Y.
    Wickerhauser, M.
    Deasy, J.
    [J]. MEDICAL PHYSICS, 2014, 41 (06) : 312 - 312
  • [10] Inverse planning and intensity-modulated radiotherapy in patients with prostate cancer
    Debus, J
    Zierhut, D
    Didinger, B
    Schlegel, W
    Wannenmacher, M
    [J]. CONTROVERSIES IN URO-ONCOLOGY, 2002, 36 : 25 - 34